Home/Filings/4/0000950170-24-069424
4//SEC Filing

Gordon Stephen 4

Accession 0000950170-24-069424

CIK 0001756262other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 5:12 PM ET

Size

8.2 KB

Accession

0000950170-24-069424

Insider Transaction Report

Form 4
Period: 2024-06-03
Gordon Stephen
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-06-032,06015,417 total
    Exercise: $38.46Exp: 2031-02-24Common Stock (2,060 underlying)
  • Exercise/Conversion

    Common Stock

    2024-06-03$38.46/sh+2,060$79,22823,359 total
  • Sale

    Common Stock

    2024-06-03$135.93/sh2,060$280,01621,299 total
Footnotes (2)
  • [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
  • [F2]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.

Documents

1 file

Issuer

TransMedics Group, Inc.

CIK 0001756262

Entity typeother

Related Parties

1
  • filerCIK 0001774274

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:12 PM ET
Size
8.2 KB